Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Doxorubicin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Burkitt Lymphoma 12 Breast Neoplasms 11 Neoplasms 10 Lymphoma, Follicular 10 Lymphoma 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Sarcoma 7 Ovarian Neoplasms 6 Hodgkin Disease 6 Endometrial Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell 5 Sarcoma, Ewing 4 Recurrence 4 Osteosarcoma 4 Neuroblastoma 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Liposarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Fallopian Tube Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Inflammatory Breast Neoplasms 3 Ganglioneuroblastoma 3 Urinary Bladder Neoplasms 2

Interventions

Dexamethasone 8 Lenalidomide 7 Bortezomib 5 pomalidomide 3 carfilzomib 3 Calcium Dobesilate 3 Prednisone 2 poly ICLC 1 ibrutinib 1 fludarabine 1 elotuzumab 1 daratumumab 1 citarinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Everolimus 1 Cyclophosphamide 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 Blood Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡